Maryland-based Neuraly surged forth from the startup gate with $36 million in Series A funding that will finance the company’s research into the development of therapies for neurodegenerative disorders.

URL
https://www.biospace.com/article/startup-neuraly-launches-with-36-million-targets-neurodegenerative-diseases/
About TEDCO
Off
Release date
Funds
Social Impact Funds
Market Search
N-STEP
Network Advisors
Rural Business Innovation Initiative
Seed Funds
Venture Funds